Cargando…

Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol

BACKGROUND: Over 4.2 million confirmed cases and more than 285,000 deaths, COVID-19 pandemic continues to harm significant number of people worldwide. Several studies have reported the impact of COVID-19 in general population; however, there is scarcity of information related to pharmacological mana...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Binny, Pallivalapila, Abdulrouf, El Kassem, Wessam, Tarannum, Asma, Al Hail, Fatema, Rijims, Mohammed, Parappil, Hussain, Bayo, Arabo Ibrahim, Ahmad, Shamsa, Nazar, Zachariah, Stewart, Derek, Al Hail, Moza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368633/
https://www.ncbi.nlm.nih.gov/pubmed/32682444
http://dx.doi.org/10.1186/s13643-020-01418-2
_version_ 1783560633533333504
author Thomas, Binny
Pallivalapila, Abdulrouf
El Kassem, Wessam
Tarannum, Asma
Al Hail, Fatema
Rijims, Mohammed
Parappil, Hussain
Bayo, Arabo Ibrahim
Ahmad, Shamsa
Nazar, Zachariah
Stewart, Derek
Al Hail, Moza
author_facet Thomas, Binny
Pallivalapila, Abdulrouf
El Kassem, Wessam
Tarannum, Asma
Al Hail, Fatema
Rijims, Mohammed
Parappil, Hussain
Bayo, Arabo Ibrahim
Ahmad, Shamsa
Nazar, Zachariah
Stewart, Derek
Al Hail, Moza
author_sort Thomas, Binny
collection PubMed
description BACKGROUND: Over 4.2 million confirmed cases and more than 285,000 deaths, COVID-19 pandemic continues to harm significant number of people worldwide. Several studies have reported the impact of COVID-19 in general population; however, there is scarcity of information related to pharmacological management and maternal and perinatal outcomes during the pandemic. Altered physiological, anatomical, and immunological response during pregnancy makes it more susceptible to infections. Furthermore, during pregnancy, a woman undergoes multiple interactions with the health care system that increases her chance of getting infected; therefore, managing pregnant population presents a unique challenge. RESEARCH QUESTIONS: What are the different clinical characteristics presented in maternal and perinatal population? What are the different maternal and perinatal outcome measures reported? What are the distinct therapeutic interventions reported to treat COVID-19? Is it safe to use “medications” used in the treatment of COVID-19 during antenatal, perinatal, postnatal, and breastfeeding? METHOD: The search will follow a comprehensive, sequential three step search strategy. Several databases relevant to COVID-19 and its impact on pregnancy including Medline, CINAHL, and LitCovid will be searched from the inception of the disease until the completion of data collection. The quality of this search strategy will be assessed using Peer Review of Electronic Search Strategies Evidence-Based Checklist (PRESS EBC). An eligibility form will be developed for a transparent screening and inclusion/exclusion of studies. All studies will be sent to RefWorks, and abstraction will be independently performed by two researchers. Risk of bias will be assessed using Cochrane Risk of Bias tool for randomized controlled trials, Newcastle–Ottawa Quality Assessment Scale for non-randomized studies, and for case reports, Murad et al. tool will be used. Decision to conduct meta-analysis will be based on several factors including homogeneity and outcome measures reported; otherwise, a narrative synthesis will be deemed appropriate. DISCUSSION: This systematic review will summarize the existing data on effect of COVID-19 on maternal and perinatal population. Furthermore, to the best of our knowledge, this is the first systematic review addressing therapeutic management and safety of medicines to treat COVID-19 during pregnancy and breastfeeding. SYSTEMATIC REVIEW REGISTRATION: This systematic review has been registered and published with Prospero (CRD42020172773).
format Online
Article
Text
id pubmed-7368633
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73686332020-07-20 Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol Thomas, Binny Pallivalapila, Abdulrouf El Kassem, Wessam Tarannum, Asma Al Hail, Fatema Rijims, Mohammed Parappil, Hussain Bayo, Arabo Ibrahim Ahmad, Shamsa Nazar, Zachariah Stewart, Derek Al Hail, Moza Syst Rev Protocol BACKGROUND: Over 4.2 million confirmed cases and more than 285,000 deaths, COVID-19 pandemic continues to harm significant number of people worldwide. Several studies have reported the impact of COVID-19 in general population; however, there is scarcity of information related to pharmacological management and maternal and perinatal outcomes during the pandemic. Altered physiological, anatomical, and immunological response during pregnancy makes it more susceptible to infections. Furthermore, during pregnancy, a woman undergoes multiple interactions with the health care system that increases her chance of getting infected; therefore, managing pregnant population presents a unique challenge. RESEARCH QUESTIONS: What are the different clinical characteristics presented in maternal and perinatal population? What are the different maternal and perinatal outcome measures reported? What are the distinct therapeutic interventions reported to treat COVID-19? Is it safe to use “medications” used in the treatment of COVID-19 during antenatal, perinatal, postnatal, and breastfeeding? METHOD: The search will follow a comprehensive, sequential three step search strategy. Several databases relevant to COVID-19 and its impact on pregnancy including Medline, CINAHL, and LitCovid will be searched from the inception of the disease until the completion of data collection. The quality of this search strategy will be assessed using Peer Review of Electronic Search Strategies Evidence-Based Checklist (PRESS EBC). An eligibility form will be developed for a transparent screening and inclusion/exclusion of studies. All studies will be sent to RefWorks, and abstraction will be independently performed by two researchers. Risk of bias will be assessed using Cochrane Risk of Bias tool for randomized controlled trials, Newcastle–Ottawa Quality Assessment Scale for non-randomized studies, and for case reports, Murad et al. tool will be used. Decision to conduct meta-analysis will be based on several factors including homogeneity and outcome measures reported; otherwise, a narrative synthesis will be deemed appropriate. DISCUSSION: This systematic review will summarize the existing data on effect of COVID-19 on maternal and perinatal population. Furthermore, to the best of our knowledge, this is the first systematic review addressing therapeutic management and safety of medicines to treat COVID-19 during pregnancy and breastfeeding. SYSTEMATIC REVIEW REGISTRATION: This systematic review has been registered and published with Prospero (CRD42020172773). BioMed Central 2020-07-18 /pmc/articles/PMC7368633/ /pubmed/32682444 http://dx.doi.org/10.1186/s13643-020-01418-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Protocol
Thomas, Binny
Pallivalapila, Abdulrouf
El Kassem, Wessam
Tarannum, Asma
Al Hail, Fatema
Rijims, Mohammed
Parappil, Hussain
Bayo, Arabo Ibrahim
Ahmad, Shamsa
Nazar, Zachariah
Stewart, Derek
Al Hail, Moza
Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol
title Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol
title_full Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol
title_fullStr Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol
title_full_unstemmed Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol
title_short Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol
title_sort maternal and perinatal outcomes and pharmacological management of covid-19 infection in pregnancy: a systematic review protocol
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368633/
https://www.ncbi.nlm.nih.gov/pubmed/32682444
http://dx.doi.org/10.1186/s13643-020-01418-2
work_keys_str_mv AT thomasbinny maternalandperinataloutcomesandpharmacologicalmanagementofcovid19infectioninpregnancyasystematicreviewprotocol
AT pallivalapilaabdulrouf maternalandperinataloutcomesandpharmacologicalmanagementofcovid19infectioninpregnancyasystematicreviewprotocol
AT elkassemwessam maternalandperinataloutcomesandpharmacologicalmanagementofcovid19infectioninpregnancyasystematicreviewprotocol
AT tarannumasma maternalandperinataloutcomesandpharmacologicalmanagementofcovid19infectioninpregnancyasystematicreviewprotocol
AT alhailfatema maternalandperinataloutcomesandpharmacologicalmanagementofcovid19infectioninpregnancyasystematicreviewprotocol
AT rijimsmohammed maternalandperinataloutcomesandpharmacologicalmanagementofcovid19infectioninpregnancyasystematicreviewprotocol
AT parappilhussain maternalandperinataloutcomesandpharmacologicalmanagementofcovid19infectioninpregnancyasystematicreviewprotocol
AT bayoaraboibrahim maternalandperinataloutcomesandpharmacologicalmanagementofcovid19infectioninpregnancyasystematicreviewprotocol
AT ahmadshamsa maternalandperinataloutcomesandpharmacologicalmanagementofcovid19infectioninpregnancyasystematicreviewprotocol
AT nazarzachariah maternalandperinataloutcomesandpharmacologicalmanagementofcovid19infectioninpregnancyasystematicreviewprotocol
AT stewartderek maternalandperinataloutcomesandpharmacologicalmanagementofcovid19infectioninpregnancyasystematicreviewprotocol
AT alhailmoza maternalandperinataloutcomesandpharmacologicalmanagementofcovid19infectioninpregnancyasystematicreviewprotocol